Department of Surgery, UNC Health Care; postdoctoral research fellow, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
N C Med J. 2022 Jul-Aug;83(4):294-303. doi: 10.18043/ncm.83.4.294.
Our objectives were to evaluate geographic access to lung cancer treatment modalities in North Carolina and to characterize how practice patterns are changing over time. We hypothesized that rural patients would be less likely to undergo treatment compared to urban patients, with widening disparities over time. We identified patients with Stage I non-small cell lung cancer (NSCLC) from 2006 to 2015 using the North Carolina Central Cancer Registry linked with Medicaid, Medicare, and private insurance claims. The primary outcome was first-course treatment: surgery, radiation, or no treatment. Calendar years were split into earlier (2006-2010) and later (2011-2015) periods. We estimated the adjusted odds ratio (OR) of rural/urban status and time period with 1) surgery and 2) any treatment (surgery or radiation) using multivariable logistic regression. Among 5504 patients, 3206 (58%) underwent surgery as initial therapy, 1309 (24%) received radiation as initial therapy, and 989 (18%) had no therapy. There were no rural-urban disparities in treatment patterns. For rural and urban patients, the odds of surgery decreased over time and the odds of radiation increased. We also found that only 48% of those receiving no treatment ever reached a surgeon or radiation oncologist. This was an insured, single-state population. Treatment preferences are unknown. Among all treated patients, whether urban or rural, there was increasing use of radiation and decreasing use of surgery over time. Many patients without treatment never had a consultation with a surgeon/radiation oncologist, and this is an actionable target for improving treatment access for early-stage NSCLC.
我们的目标是评估北卡罗来纳州肺癌治疗方式的地理可达性,并描述随着时间的推移治疗模式如何变化。我们假设与城市患者相比,农村患者接受治疗的可能性较低,且随着时间的推移差距会越来越大。我们使用北卡罗来纳州中央癌症登记处与医疗补助、医疗保险和私人保险索赔相关联的信息,从 2006 年至 2015 年确定了 I 期非小细胞肺癌(NSCLC)患者。主要结局是首次治疗:手术、放疗或不治疗。日历年度分为早期(2006-2010 年)和晚期(2011-2015 年)。我们使用多变量逻辑回归估计了农村/城市状况和时间期与 1)手术和 2)任何治疗(手术或放疗)的调整后的优势比(OR)。在 5504 名患者中,3206 名(58%)接受手术作为初始治疗,1309 名(24%)接受放疗作为初始治疗,989 名(18%)未接受治疗。治疗模式没有城乡差异。对于农村和城市患者,手术的几率随着时间的推移而降低,放疗的几率增加。我们还发现,只有 48%的未接受治疗的患者曾接受过外科医生或放射肿瘤学家的治疗。这是一个参保的单一州人口。治疗偏好未知。在所有接受治疗的患者中,无论城乡,放疗的使用呈上升趋势,手术的使用呈下降趋势。许多未接受治疗的患者从未与外科医生/放射肿瘤学家进行过咨询,这是改善早期 NSCLC 治疗机会的一个可行目标。